| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.03. | Barclays raises Lifestance Health stock price target on growth outlook | 12 | Investing.com | ||
| 02.03. | LifeStance Health Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.02. | 6 Analysts Assess LifeStance Health Gr: What You Need To Know | 1 | Benzinga.com | ||
| 26.02. | KeyBanc raises Lifestance Health stock price target on productivity | 1 | Investing.com | ||
| 26.02. | Lifestance outlines $1.615B-$1.655B 2026 revenue target while advancing AI, EHR initiatives and $100M buyback | 3 | Seeking Alpha | ||
| 25.02. | LifeStance stockholders plan 25M share offering | 1 | Investing.com | ||
| 25.02. | LifeStance: Aktionäre planen Verkauf von 25 Millionen Aktien | 1 | Investing.com Deutsch | ||
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 25.02. | LifeStance Health Group, Inc.: LifeStance Health Group Announces Launch of Secondary Public Offering | 1 | GlobeNewswire (USA) | ||
| 25.02. | LifeStance Health Group, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 25.02. | LifeStance Health Group, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 25.02. | LifeStance Health Q4 2025 slides: revenue beats, EBITDA soars 49% | 1 | Investing.com | ||
| 25.02. | Earnings Summary: LifeStance Health Gr Q4 | 1 | Benzinga.com | ||
| 25.02. | LifeStance Health Group reports Q4 results; introduces FY26 outlook | 1 | Seeking Alpha | ||
| 25.02. | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | 433 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 24.02. | Lifestance Health vor Quartalszahlen: Weg zur Profitabilität im Fokus | 1 | Investing.com Deutsch | ||
| 02.02. | LifeStance Health Gr Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) | 2 | Benzinga.com | ||
| 22.01. | Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes | 1 | Insider Monkey | ||
| 08.11.25 | LifeStance (LFST) Soars 30% on Q3 Earnings Blowout | 1 | Insider Monkey | ||
| 06.11.25 | Lifestance anticipates mid-teens revenue growth for 2026 while raising adjusted EBITDA guidance amid record productivity gains | 6 | Seeking Alpha | ||
| 06.11.25 | LifeStance Health Group, Inc. - 10-Q, Quarterly Report | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,190 | +0,36 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
16.04.2026 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,950 | +0,67 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,350 | +0,03 % | SIEMENS HEALTHINEERS AG im strategischen Gleichgewicht | ||
| CARL ZEISS MEDITEC | 27,740 | +1,76 % | SCHOCKMELDUNG bei Carl Zeiss Meditec: Könnte die Aktie jetzt komplett einbrechen? - Das sollten Sie jetzt wissen | ||
| TELADOC HEALTH | 4,856 | +3,52 % | Teladoc Health, Inc.: Teladoc Health to Announce First Quarter 2026 Financial Results | ||
| ROKU | 94,80 | +2,33 % | Roku surpasses 100m streaming households | ||
| DEXCOM | 52,00 | -0,38 % | Here's Why You Should Add DexCom Stock to Your Portfolio Now | ||
| INMODE | 12,110 | +0,17 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| PETMED EXPRESS | 1,944 | -2,02 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| ORGANON | 8,012 | +2,35 % | Organon gains as Sun Pharma, Grünenthal said to seek takeover deals | ||
| TANDEM DIABETES | 17,100 | -2,29 % | Truist upgrades Tandem Diabetes Care stock rating on Pay/Go model | ||
| INSULET | 173,15 | +0,90 % | How Insulet taps into pop culture to spread the word on Omnipod through 'Scrubs,' Marvel | ||
| MOLINA HEALTHCARE | 126,95 | +2,01 % | Healthcare-Wette von Burry: Molina Healthcare stürzt brutal ab: Was bedeutet der Crash für Anleger? | © Foto: DallE - OpenAISchock-Meldung: Molina Healthcare stürzt um 33 Prozent nachbörslich ab - Analysten warnen vor tieferem Absturz! Was ist da los?Molina Healthcare hat eine schwache Prognose für... ► Artikel lesen | |
| QUIDELORTHO | 10,650 | -28,19 % | QuidelOrtho Corporation: QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance | SAN DIEGO, April 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, today... ► Artikel lesen |